We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Check the tariff classification for anti-stress balls and anti-stress items.
Check the tariff classification for posture shirts and waistcoats.
Statistics on the Police use of TASER ® X26 conducted energy devices across England and Wales.
Check if you need to tell DVLA about a health or medical condition, how to report medical conditions to DVLA
A resource for clinicians to give to their patients.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 8 July, become the first regulator in the world to approve elinzanetant (Lynkuet) for the treatment of moderate to severe vasomotor symptoms (hot flushes) associated with the menopause.
A resource designed to support policymakers and others in using the Policy Stress-testing tool described in the Futures Toolkit.
Product Safety Report for TiaTio Concentrated Serum presenting a serious chemical risk
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).